Cellectis (CLLS) Cash from Discontinued Operations (2022 - 2023)
Cellectis' (CLLS) quarterly Cash from Discontinued Operations came in at 1000.0 in Q4 2023, up 100.03% year-on-year from 499.93 in Q4 2022, and up 200.0% quarter-over-quarter from 1000.0 in Q3 2023.
Cellectis (CLLS) Cash from Discontinued Operations (2022 - 2023) Analysis & Trends
Cellectis' Cash from Discontinued Operations history runs 2 years deep, the most recent figure standing at 1000.0 for Q4 2023.
- On a quarterly basis, Cash from Discontinued Operations rose 100.03% year-over-year to 1000.0 in Q4 2023; TTM through Dec 2023 was 3644000.0, a 80.41% increase from a year earlier, with the FY2023 full-year figure at 3644000.0, up 80.41% from the prior year.
- Cash from Discontinued Operations climbed to 1000.0 in Q4 2023 per CLLS's latest filing, from 1000.0 in the prior quarter.
- Across five years, Cash from Discontinued Operations topped out at 1000.0 in Q4 2023 and bottomed at 8322000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -1.67 Mn |
| Jun 30, 2023 | -1.67 Mn |
| Mar 31, 2023 | -1.97 Mn |
| Mar 31, 2023 | -1.97 Mn |
| Dec 31, 2022 | -3.47 Mn |
| Dec 31, 2022 | -3.47 Mn |
| Sep 30, 2022 | -8.32 Mn |
| Sep 30, 2022 | -8.32 Mn |
| Jun 30, 2022 | -366,000.00 |
| Jun 30, 2022 | -366,000.00 |
| Mar 31, 2022 | -6.44 Mn |
| Mar 31, 2022 | -6.44 Mn |